The possible roles of Src family kinases in the enhanced malignant properties of melanomas related to GD3 expression were analyzed. Among Src family kinases only Yes, not Fyn or Src, was functionally involved in the increased cell proliferation and invasion of GD3-expressing transfectant cells (GD3+). Yes was located upstream of p130Cas and paxillin, and at an equivalent level to focal adhesion kinase. Yes underwent autophosphorylation even before serum treatment, and showed stronger kinase activity in GD3+ cells than in GD3-cells following serum treatment. Co-immunoprecipitation experiments revealed that Yes bound to FAK or p130Cas more strongly in GD3+ cells than in GD3-cells. As a possible mechanism for the enhancing effects of GD3 on cellular phenotypes, it was shown that majority of Yes was localized in GEM/rafts in GD3+ cells even before serum treatment, while it was scarcely detected in GEM/rafts in GD3-cells. In vitro kinase assay of Yes revealed that coexistence of GD3 with Yes in membranous environments enhances the kinase activity of GD3-cells-derived Yes toward enolase, p125 and Yes itself. Knockdown of GD3 synthase resulted in the alleviation of tumor phenotypes and reduced activation levels of Yes. Taken together these results suggest a role of GD3 in the regulation of Src family kinases.
Gangliosides, sialic acid-containing glycosphingolipids, are considered to play essential roles in the development and functions of nerve tissues in vertebrates, since they are enriched in nervous systems and their composition is well conserved among species (1, 2) . Some gangliosides are also expressed in neuroectodermderived cancers such as malignant melanomas and neuroblastomas (3) . Besides being markers of cancers, it has been recognized that gangliosides play roles as modulators of signaling in cancer cells based on the genetic manipulation of glycosylation machineries (4) . Ganglioside GD3, in particular, is thought to play a key role in malignant melanoma.
Using a GD3-defective mutant of SK-MEL-28 subline N1 cell (5) , the effects of re-expression of GD3 in N1 cells on the phenotypes of melanoma cells have been analyzed. Adaptor molecules p130Cas and paxillin were the major molecules activated and involved in the enhanced cell growth and invasion related to GD3 expression (6) . Focal adhesion kinase (FAK) also undergoes activation under GD3 expression, and is involved in the enhanced malignant properties in GD3+ transfectant cells (7) . All these experiments were performed by stimulating melanoma cells with fetal calf serum (FCS) after serum starvation. Similar experiments have been performed using fibroblasts (8) , hamster melanoma (9) and CHO cells (10) , and the same involvement of GD3 has been reported. Opposite effects of GD3 on vascular smooth muscle cells were also reported (11, 12) .
Further more, effects of GD3 on cell adhesion were analyzed (13) . Expression of GD3 apparently enhanced cell attachment to 2 extracellular matrix (ECM), and increased phosphorylation levels of adaptor molecules during adhesion (13) . These results suggested that signals mediated via growth factor receptor(s) and those mediated via adhesion receptor integrins might converge in the vicinity of cell membrane.
In this study, the roles of Src family kinases in the enhancement of the malignant properties of melanoma cells involving GD3 expression have been examined. Although several members of Src family kinases were expressed in the melanoma cells, only Yes was functionally involved in the enhanced signaling that contributes to the malignant phenotypes of melanoma cells. Mechanisms by which Yes is activated under the influence of GD3 were extensively analyzed.
EXPERIMENTAL PROCEDURES
Antibodies-Anti-phosphotyrosine mAb PY20, anti-FAK (mouse mAb IgG1), anti-paxillin (mouse mAb IgG1), anti-Yes (mouse mAb IgG1), anti-Fyn (mouse mAb IgG2b), anti-Lck (mouse mAb IgG2a), anti-Lyn (mouse mAb IgG1), and anti-flotillin-1 (mouse mAb IgG1) were from BD transduction (San Jose, CA). Anti-flotillin-1 (rabbit IgG, H-104), anit-p130Cas (rabbit IgG, C-20), anti-FAK (rabbit IgG, C-20), anti-c-Src (rabbit IgG, N-16), anti-c-Src (mouse mAb IgG2a), and anti-Lyn (rabbit IgG, 44) were from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-phospho-Src family (tyr416, rabbit IgG) was from Cell Signaling Technology (Beverly, MA o C in a humidified atmosphere containing 5 % CO 2. Construction of a cDNA expression vector of human α2,8-sialyltransferase (GD3 synthase) was as described previously (14) , and GD3+ transfectant cells were established by trasfecting SK-MEL-28-N1 cells with the cDNA expression vectors and selecting G-418-resistant clones in the presence of G418 (400 µg/ml) (Sigma, St Louis, MO). The transfectant cells were screened by flow cytometry using mAb R24 (anti-GD3), and maintained in D-MEM with 7.5% FCS and G418 (400 µg/ml). Flow cytometry-The cell surface expression of GD3 was analyzed by flow cytometry (Beckton Dickinson, Mountain View, CA) as described previously (6) . Control samples were usually prepared using non-relevant mAbs with same subclasses for individual mAbs. In vitro invasion assay-Invasion assays were performed with Boyden chamber as described 3 previously (6) with some modifications. In brief, Matrigel (Becton Dickinson) was diluted with icecold PBS (100 µg/ml), added 0.6 ml to each filter (polyethylene terephthalate membrane, 8-µm pore size, 23.1 mm in diameter; Falcon 3093), and left to be polymerized overnight. The membrane was reconstituted with serum-free medium. The lower chamber (6-well plate; Falcon 3502) was filled with the culture medium with or without serum before the chamber was assembled. Cells (1~8 x  10 5 cells/well) were added to serum-free medium in the upper chamber and incubated for 24 h, then the cells on the surface of the filter were stained with Giemsa (Wako, Osaka), then counted under microscopy. BrdU uptake-Cells grown on a 60-well plate were incubated in the presence of 5-bromo-2-deoxyuridine (BrdU) for 14 h according to the instruction of Cell Proliferation kit TM (Amersham Biosciences), then fixed with acid-ethanol for 30 min. The cells were immunostained with antiBrdU antibody and Alexa546-conjugated antimouse antibody (Molecular Probes, Invitrogen). The BrdU positive cells were observed by a fluorescence microscopy (BX51, OLYMPUS, Tokyo) and the percentage of BrdU positive cells were calculated. Cells (2 x 10 3 ) were seeded in 98-well plates. MTT assay was performed by assessing the reduction of MTT to formazan based on the absorbance at 590 nm using an ELISA reader Immuno Mini NJ-2300 (System Instruments, Tokyo). Preparation of cell lysates-Two or Six x 10 5 cells were plated in a 6 or 10-cm dish respectively, and serum-starved for 12 h before treatment with FCS. Then, cells were treated with FCS for 0-120 min at 37 o C. Cells were lysed with a lysis buffer (20 mM Tris-HCl, pH7.5, 150 mM NaCl, 1mM Na 2 EDTA, 1mM EGTA, 1% Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM β-glycerophosphate, 1 mM Na 3 VO 4 , leupeptin (1 µg/ml), 1 mM PMSF) and then, insoluble materials were removed by centrifugation. Western immunoblotting (IB)-Lysates were separated with SDS-PAGE using 10-15% gels. The separated proteins were transferred onto an Immobilon-P TM membrane (Millipore, Bedford, MA). Blots were blocked with 3% BSA in phosphate buffered saline (PBS) containing 0.05% Isolation of GEM/Raft fraction-Glycolipidenriched microdomains (GEM)/raft membrane microdomains were prepared using a detergent extraction method essentially as described by Mitsuda et al (15) . Cells were plated at a density of 5 x 10 5 per 15-cm dish (greiner bio-one, Frickenhausen, Germany) and cultured up to 80% confluency, and six dishes of cells were used for each preparation. After being washed twice with ice-cold PBS, the cells were collected, suspended in 1 mL of TNE/Triton X-100 buffer (1% Triton X-100, 25 mM Tris-HCl, pH7.5, 150 mM NaCl, 1mM EGTA), then Dounce homogenized 20 times, and mixed with an equal volume of 80% sucrose (w/v). Then, samples (2 mL) were placed at the bottom of Ultra-Clear Centrifuge Tubes TM (Beckman Instruments, Fullerton, CA). Two ml of 30% sucrose in TNE buffer without Triton X-100 was laid on top of the samples, and 1 mL of 5% (w/v) sucrose in TNE buffer without Triton X-100 was laid on top. The samples were centrifuged at 105,000 x g in a MLS50 rotor (Beckman Instruments) for 16 h at 4 o C. The entire procedure was performed at 4 o C. From the top of the gradient, 0.5 mL each of fraction was collected to yield 10 fractions. Furthermore, GEM/raft fraction was prepared using a non-detergent extraction method essentially as described by Nishio et al. (16) . Cells were plated at a density of 5 x 10 5 per 15-cm dish and cultured up to 80% confluency, and six dishes of cells were used for each preparation. After being washed twice with icecold PBS, the cells were scraped in 1 ml of 0.5 M sodium carbonate buffer, pH 11.0. The cells were sequentially homogenized using a loose fitting Dounce homogenizer (10 strokes), a Polytron tissue grinder (three 10-s bursts), and a sonicator (three 20-s bursts). All procedures were carried out at 4°C. The homogenate (1 ml) was then adjusted to 45% (w/v) sucrose by adding 1 ml of 90% (w/v) sucrose prepared in 2x MNE buffer (25 mM Mes, pH 6.5, 150 mM NaCl, 5 mM EDTA). The final pH of the mixture was 10.2. A discontinuous sucrose gradient was formed by overlaying 2 ml of 35% (w/v) sucrose onto the mixture, and then 1 ml of 5% (w/v) sucrose. Both of these layers were prepared with MNE containing 0.25 M sodium carbonate. The samples were centrifuged at 105,000 x g in a MLS50 rotor (Beckman Instruments) for 16 h at 4°C. From the top of the gradient, 0.5 ml each of fraction was collected to yield 10 fractions. The components in each fraction were concentrated by centrifugation at 100,000 x g for 2 h at 4°C in MNE buffer, and precipitates were resolved in the lysis buffer (10 mM Tris-HCl, pH7.4, 150 mM NaCl, 10 mM MgCl 2 , 0.5% Nonidet P-40, 1 mM Na 3 VO 4 ) and used for Western immunoblotting. To investigate distribution patterns of phosphorylated Yes inside/ outside of GEM/rafts, antibodies on the membranes were stripped using Western Blot Stripping Buffer for 1 h at 37°C after immunoblotting by an anti-phospho-Src family (Tyr 416) antibody. Then, the membrane was blocked with 3% BSA in PBS containing 0.05% Tween-20 for 1 h, and was probed with an antiYes antibody. Immunocytostaining-Cells were fixed in paraformaldehyde (4% in PBS for 10 min) and then incubated with 0.1% Triton X-100 in PBS for 5 min at room temperature. After being washed with PBS, nonspecific binding was blocked with 10% normal goat serum (NGS) in PBS for 15 min at room temperature. The fixed cells were incubated with primary antibodies in PBS containing 10% NGS over night at 4°C. After being washed, nonspecific binding was blocked with 10% NGS in PBS for 15 min at room temperature, they were incubated with anti-mouse IgG1-Alexa Fluor 555 and anti-rabbit IgG-Alexa Fluor 488, or antimouse IgG3-Alexa Fluor 488 in PBS containing 10% NGS for 60 min at room temperature. The resulting staining patterns were imaged using a confocal microscope (Fluoview FV500, Olympus, Tokyo, Japan). To 5 stably knockdown GD3 synthase in SK-MEL-28, we used an shRNAi expression plasmid as described previously (17) . After transfection of the anti-GD3 synthase shRNAi vector into SK-MEL-28 and subsequent selection with puromycin (0.4 µg/ml) (Sigma, St Louis, MO), GD3-knockdown clones were established. Image analysis-To analyze the band intensities in IB and the autoradiograph, bands were scanned by Adobe Photoshop CS2 or Typhoon TM 8600 and quantified using NIH Image 1.61. Statistical analysis-Statistical significance of data was determined using Student's t test.
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay-

Knockdown of GD3 synthase with a short hairpin (sh)RNAi in a melanoma cell line SK-MEL-28-
RESULTS
Generation of GD3-expressing lines from SK-MEL-28-N1.
As previously described (6), SK-MEL-28-N1 was transfected by an expression vector of GD3 synthase cDNA, resulting in the establishment of GD3+ transfectant cells, G5 and G11. As shown in Figure 1 , G5 and G11 showed definite expression of GD3, while transfectants of the vector alone, V5 and V9 showed no GD3. In TLC, the transfectant contained 67.1% of GD3 (ca 0.27 µg/mg wet tissue) compared with that in SK-MEL-28 as shown in the previous report (Supplemental Figure S1 ) (7) . A few faint bands were detected as well as GD3 bands, suggesting that a minor portion of GD3 was converted. SK-MEL-28-N1 and controls derived from it showed no band of GD3 (below 0.005 µg/mg wet tissue) in TLC as suggested in flow cytometry.
Expression of Src family kinases and their involvement in the malignant properties of melanoma cells.
To determine the expression of Src family kinases in melanoma cells, immunoprecipitation and immunoblotting were performed with antibodies for individual Src family kinases. These results showed that the expression levels of Yes and Fyn were fairly high, while those of Src and Lyn were low (Figure 2A and 2B). Expression of Lck was not detected (Supplementary Figure S2) . Involvement of Src family kinases in the cell proliferation and invasion was analyzed by knockdown with siRNAs against individual Src family kinases. Between two siRNAs for the knockdown of Yes, highly effective siRNA (YES1) was selected ( Figure 2C ). Because a single knockdown of Yes was not enough, repeated transfection of YES1 siNRA was performed, resulting in sufficient reduction of Yes protein ( Figure 2D ). To examine specificity of YES1 siRNA, it was analyzed whether Fyn protein was affected by YES1. Consequently, no effect on Fyn was observed ( Figure 2E ). After the transfection of individual siRNAs into GD3+ transfectant cells and GD3-vector control cells, cell proliferation and invasion activity were analyzed with BrdUrd assay and the Boyden chamber invasion assay, respectively. As shown in Figure 2F , tyrosine phosphorylation levels of FAK, p130Cas, and paxillin were definitely suppressed by knockdown of Yes, although total protein amounts of them were not affected in GD3+ cells. The proliferation and invasion activities were markedly reduced after knockdown of Yes in GD3+ cells (G5 and G11) ( Figure 2G and 2H), while they showed no change by knockdown of Yes in GD3-cells (V5 and V9). On the other hand, knockdown of Fyn in GD3+ cells did not affect phosphorylation levels of FAK, p130Cas, and paxillin ( Figure 2I ). Furthermore, the proliferation and invasion activity showed no change by knockdown of Fyn ( Figure 2J and 2K).
(data of Src are in Supplemental Figure S3 )
Yes is located up-stream of p130Cas and paxillin, and in equal level to FAK. In order to clarify the position of Yes in the signaling pathway, knockdown of Yes, FAK, p130Cas, and paxillin was performed with siRNAs. As shown in Figure 3A and 3B, after knockdown of p130Cas, or paxillin with individual siRNAs, total amounts p130Cas or paxillin were definitely suppressed resepectivly, while tyrosine phosphorylation of Yes was not affected. After knockdown of FAK, phosphorylation levels of Yes were partially suppressed. On the other hand, after knockdown of Yes, phosphorylation levels of p130Cas, and paxillin were strongly suppressed, and that of FAK was partially suppressed ( Figure 2F ). These results indicated that Yes was located up-stream of p130Cas and paxillin, and at an equivalent level to FAK.
Enhanced phosphorylation and kinase activity of Yes under GD3 expression. The time course of tyrosine phosphorylation levels of Yes in GD3+ cells and GD3-cells after FCS treatment was analyzed. Cells were treated with FCS after serum starvation for 12 h, and tyrosine phosphorylation levels of Yes were observed up to 120 min after addition of FCS ( Figure 4A and 4B). Stronger tyrosine phosphorylation of Yes in GD3+ cells than in GD3-cells was observed up to 15 min 6 after stimulation of FCS. Interestingly, the tyrosine phosphorylation level at Tyr 416 was already increased in GD3+ cells even before FCS treatment. Then, in vitro kinase assays were done with enolase as a substrate to determine whether GD3 enhanced kinase activity of Yes. We conducted in vitro kinase assay using 3 µg enolase and 1 µM ATP hereafter based on the preliminary experiments (Supplemental Figure S4) . The bands of autophosphorylated Yes, phosphorylated p125, and phosphorylated enolase were stronger in GD3+ cells than in GD3-cells at both 0 and 15 min after FCS treatment ( Figure 4C and 4D) , suggesting that Yes is already activated before FCS treatment, although not fully, and activated more strongly by FCS in GD3+ cells.
GD3 expression caused enhanced association of Yes with FAK, and p130Cas. In order to investigate whether expression of GD3 in melanoma cells is involved in the formation of complexes of Yes with FAK and/or p130Cas after FCS treatment, immunoprecipitation/immunoblotting was performed using lysates from GD3+ and GD3-melanoma cells during the FCS treatment. As shown in Figure 5A and 5B, the band intensities of Yes co-precipitated with FAK from 0 to 120 min were generally higher in GD3+ transfectant cells. p130Cas was also associated with Yes much more in GD3+ transfectants compared to GD3-cells ( Figure 5C and 5D) . The presence of equivalent amounts of Yes in both types of cells was confirmed (Supplemental Figure S5) . Consequently, molecular complexes consisting of Yes and FAK and/or p130Cas were formed more strongly in GD3+ cells than in GD3-cells.
Localization of Yes in the GEM/Rafts. In order to clarify molecular mechanisms by which kinase activity, phosphorylation of Tyr 416, and complex-formation of Yes were increased in GD3+ transfectant cells, the intracellular localization of Yes in the GEM/raft was analyzed. Sucrose density gradient fractionation of Triton X-100 extracts was performed using flotillin-1 as a marker of GEM/rafts. It was detected in fractions 2-4 (Supplemental Figure S6) . Bands of Yes were found at much higher levels in GEM/raft fractions of the GD3+ cells compared to GD3-cells at time 0, while its bands in GEM/raft fractions were found in GD3-control cells at the same level as GD3+ transfectant cells at 30 min after FCS treatment ( Figure 6A, 6B and 6C ). Both levels of phosphorylated Yes and ratios of phosphorylated Yes to total Yes in GEM/raft fractions were significantly higher in GD3+ transfectant cells than in GD3-control cells both at time 0 and 30 min ( Figure 6D, 6E, and 6F) . On the other hand, ratios of phosphorylated Yes to total Yes in non-GEM/raft fractions of GD3-cells were almost equivalent to those in GD3+ cells both at time 0 and 30 min. These results suggested that Yes in GEM/raft fractions might be constitutively activated in GD3+ cells. Furthermore, similar patterns of Yes localization were observed when a non-detergent method was used for the preparation (Supplemental Figure S7) .
Yes colocalized with GD3 and flotillin-1 before FCS treatment in GD3+ cells. Yes colocalized with flotillin-1 only in GD3+ cells at time 0, while its colocalization was almost equivalent between GD3+ cells and GD3-cells at 30 min after FCS treatment ( Figure 7A ). Yes colocalized with GD3 in GD3+ cells as expected ( Figure 7B ). These results well corresponded with those in Figure 6 .
Liposome-embedded GD3 enhanced kinase activity of Yes from GD3-cells. We conducted in vitro kinase assays using immunoprecipitated Yes from GD3-cells in the presence of liposomeembedded GD3 to examine effects of GD3 on the kinase activity in membrane-like enviroment. Effects of direct addition of GD3 on the kinase activity of immunoprecipitated Yes were shown in Supplemental Figure S8 , showing some increase in its kinase activity at 1-50 µM. As shown in Figure 8A , 8C, 8E and 8G, Yes kinase activity was higher in samples with liposome-embedded GD3 than in samples with liposome only. The effects of GD3-liposome were dose dependent, and the kinase activity of Yes was enhanced particularly at around 5 µM of GD3-liposome. On the other hand, kinase activity of Yes from GD3-cells did not change in the presence of liposomeembedded GM1 or GD1a (Supplemental Figure  S9A-S9D) . Furthermore, kinase activity of Yes from GD3+ cell was significantly reduced in the presence of liposome-embedded GM1 ( Figure 8B , 8D, 8F and 8H). The kinase activity was reduced particularly at around 5 µM of GM1-liposome. These results suggested the possibility that kinase activity of Yes was oppositely regulated by GD3 and GM1 in in vitro kinase assay, and probably in melanoma cells.
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Effects of GD3 synthase knockdown in SK-MEL-28 by shRNAi. After the transfection of SK-MEL-28 with the shRNAi expression plasmid, two GD3 synthase-knockdown clones (KF10T-1 and KF10T-2) were established. A control clone transfected with PH1-RNA puro alone (VC-A) was also isolated ( Figure 9A ). To clarify the effects of GD3 synthase knockdown on cancer properties, MTT assay and invasion assay were performed. In MTT assay, the GD3 synthaseknockdown cells showed markedly decreased cell growth compared to the control cell and the parent cell line ( Figure 9B ). The invasion assay revealed that GD3 synthase-knockdown cells had much lower invasion activity than the controls ( Figure  9C ), indicating reduced malignant properties in the GD3 synthase-knockdown cells. Suppressed phosphorylation of Yes by GD3 synthase knockdown. The time course of tyrosine phosphorylation levels of Yes in GD3 synthaseknockdown cells as well as control cells after FCS treatment was analyzed. Cells were treated with FCS after serum starvation for 12 h, and tyrosine phosphorylation levels of Yes were observed up to 60 min ( Figure 9D and E). Significantly lower tyrosine phosphorylation of Yes in GD3 synthaseknockdown cells than in the control cells was observed before FCS treatment and 60 min after stimulation of FCS also. All these results well corresponded with those observed in GD3 synthase-overexpression experiments.
DISCUSSION
Following the cloning of cDNAs of glycosyltransferases, such as of GD3 synthase (14) , the expression and role of gangliosides in cancer cells has been studied, particularly in malignant melanomas (6, 18), T-cell leukemias (19) and lung cancers (20) . In particular, strong enhancement of activation of adaptor molecules such as p130Cas and paxillin and their involvement in the malignant properties of melanomas under GD3 expression have been demonstrated. Roles for FAK in the activation of p130Cas and paxillin were also elucidated (7). However, no molecules interacting with GD3 in the vicinity of cell membrane to generate strong growth and/or invasion signals have been identified.
Src family of non-receptor protein tyrosine kinases plays critical roles in the regulation of various biological signals for cell growth, adhesion, motility, survival and angiogenesis (21) . Constitutive activation of Src family kinases often results in the induction of malignant transformation of a wide variety of cell lineages. High levels of expression of Src family kinases are also found in many cancer tissues. They are also associated with progression and metastasis as well in the evolution of cancers (21) .
In particular, Yes has been detected in colon cancers (22) and breast cancers, and less frequently in gastric cancers (23) , and malignant melanomas (24) . c-Yes was activated in colorectal carcinoma liver metastases (25) , indicating that elevated c-Yes kinase activity in liver metastases was associated with a worse prognosis (25) . Differential behaviors between Src and Yes during mitosis of colon carcinoma cells were also reported (26) . Namely, Src activity increased and Yes activity decreased during mitosis. Further more, increase in c-Yes expression level and activity promoted motility but not proliferation of colon cancer cells (22) . All these results suggested that Yes is implicated in colon cancers with differential ways of regulation, mechanisms, and resulting effects compared with Src.
In melanomas, elevated expression of Yes and higher tyrosine kinase activity was detected in a wide range of melanoma cells than in normal melanocytes (24) . Average kinase activity of cYes was 5-10-fold higher in melanomas than melanocytes, suggesting that derangement of expression of the c-Yes tyrosine kinase might have a role in the malignant progression of the human melanocytes. An intriguing point was that c-Src did not show increased expression. In human brain-metastatic melanoma cells, treatment of cells with neurotrophins resulted in the increase of the protein tyrosine kinase activity of c-Yes but not of c-Src (27) . These results suggest that c-Yes is mainly activated by either intrinsic or extrinsic factors among Src family kinases in human melanomas, and this signaling causes increased cell growth and/or metastasis of melanoma cells. Actually, c-Yes has been more strongly implicated than c-Src in melanomas, and might make a more significant contribution than c-Src in the natures of melanomas.
GEM/rafts have been considered to be platforms for the regulation of various bio-signals as well as endocytosis and cholesterol turn over (28).
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Among molecules localized in GEM/rafts, Gproteins and Src family kinases have been known to be localized at the reverse side of cell membrane in GEM/rafts (29) . Src is known to undergo myristylation resulting in the membrane anchoring to efficiently express its function (30) . Yes also undergoes acylations and play roles on the cell membrane (31). However, Yes was preferentially localized in lipid rafts, whereas most Src was in non-raft fractions in PC12 cells (32) . This difference in the intracellular localization between Yes and Src might explain the results of our knockdown experiments, i.e. only Yes showed significant effects on tumor phenotypes after siRNA treatment (Figure 2 , Supplemental Figure S3 ).
The alteration in the location inside/outside of GEM/rafts and in activation levels of Yes under GD3 expression, appeared to be critical for the malignant properties of melanoma cells. Here, Yes appeared to be constitutively activated in GD3+ cells, i.e. Yes was already phosphorylated even before treatment with FCS, though not fully. Namely, high levels of GD3 in GEM/rafts should modulate natures of Yes and activate without extrinsic stimulation. Therefore, already activated Yes in GEM/rafts might be able to induce stronger activation signals upon the stimulation with FCS in GD3+ cells than in GD3-cells. This was reflected in the increased kinase activity of Yes as phosphorylated bands of Yes, p125 and enolase in GD3+ cells ( Figure 4C ). Consequently, absolute activation levels of Yes before and during FCS stimulation should be crucial to enhance malignant tumor phenotypes in GD3+ cells.
There is also other possibility that high levels of GD3 might alter the physico-chemical nature of GEM/rafts that affects the intracellular localization of signaling molecules and receptors. Changes of Yes localization during GD3 expression might be addressed using an inducible gene expression system. As shown by analysis of GD3 and Lyn in granular cells of cerebellum, GD3 and Yes might have physical association in the context of cell membrane (33) . Association of GD3 and Yes could be observed in preliminary experiments in our laboratory (unpublished data).
Liposomes are cell membrane-mimicking structures useful to form cell membrane-like environments (34) . In particular, interaction between glycosphingolipids and other membrane molecules should be examined under the physiological situation based on the reconstitution of "proteo-liposomes" (35). In this study, we attempted to construct artificial environments to include glycolipids and signaling molecules. As we expected, GD3 and GM1 showed differential effects on the bio-signals similar to their effects found in the living cells (7, 36, 15) . GD1a showed no significant effects on the kinase activity of Yes. All these results are in good agreement with our previous reports. Namely, monosialyl gangliosides such as GM1 and GM2 showed suppressive roles in cell proliferation (15) . Anti-metastatic activity in a murine lung cancer cell line was also reported (36), suggesting that monosialyl gangliosides might have opposite activity with disialyl gangliosides with tandem sequence such as GD3.
This kind of approach as reported in this study should be effective to analyze glycolipid functions in the context of cell membrane, since complex factors are actually involved in the regulation of signaling molecules with glycolipids embedded into the lipid bilayer containing cholesterol, phospholipids, sphingo-myelin and various proteins. However, re-constitution of artificial lipid rafts containing glycolipids, glycoproteins and Src family kinases in their native forms needs much more efforts and time for technical development. In vitro kinase assay was done with enolase as a substrate to determine whether GD3 enhances kinase activity of Yes. G5 (GD3+) and V9 (GD3-) were treated with FCS after serum starvation for 12 hrs, and Yes was immunoprecipitated from their lysates, then in vitro kinase assay was performed using 3 µg enolase and 1 µM ATP. (D) Relative intensity of bands in C was measured using NIH image 1.61 and plotted after correction with those of Yes. The experiments were performed by triplicates, and average values ±SD were presented. The asterisks indicate p < 0.05 (*) and p < 0.01 (**). Note that the bands of autophosphorylated Yes, phosphorylated p125 and phosphorylated enolase were stronger in GD3+ cells than those in GD3-cells at both 0 min and 15 min after FCS treatment. 
